Back to Search Start Over

972 Phase I study of cyclophosphamide and docetaxel (taxotere®) in solid tumors

Authors :
Valero, V.
Esparza, L.
Patel, S.
Theriault, R.
Pazdur, R.
Ayoub, J.P.
Qasim, M.
Rodriguez, E.
Bellet, R.
Hortobagyi, G.
Source :
European Journal of Cancer; November 1995, Vol. 31 Issue: 6 pS202-S202, 1p
Publication Year :
1995

Abstract

Twelve patients (pts) received cyclophosphamide (CTX) as a 1hr infusion followed by Taxotere (TXT) as a 1hr infusion every 21 days. Dose levels were 0: CTX/TXT 600/60mg/m2(6 pts), 1: CTX/TXT 600/75mg/m2(3 pts), 2: CTX/TXT 700/75mg/m2(3 pts). Pts were premedicated with dexamethasone 8mg B. I. D. at day 0–4 and oral ondansetron.

Details

Language :
English
ISSN :
09598049
Volume :
31
Issue :
6
Database :
Supplemental Index
Journal :
European Journal of Cancer
Publication Type :
Periodical
Accession number :
ejs10712523
Full Text :
https://doi.org/10.1016/0959-8049(95)96221-X